The purpose of the study is to validate the effectiveness of theVI ByPass Syringe™ device to effectively isolate contaminates in a worst-case scenario.
The purpose of the study was to determine the potential hemolytic activity, via the induction of increased levels of free plasma hemoglobin in rabbit blood, in response to the Vascular Integrity™ Technology
The purpose of this product pilot was to measure the ease of use of a new blood collection device. Product compliance it crucial for optimal blood culture accuracy.
Hemolysis is the most common source of error in laboratory samples; it can potentially affect the results of several frequently ordered lab tests, and is responsible for almost 60% of rejected samples,1,2 requiring re-collection.
Blood culture contamination (BCC) increases length of stay (LOS) and leads to unnecessary antimicrobial therapy and/or hospital-acquired conditions (HACs).
The purpose of this study is to validate Vascular Integrity’s ByPass Syringe with Sliding fluid seal™ performs effectively in isolating waste collection contaminates (diversion) during fluid collection.
Hospital-acquired anemia (HAA) is a fairly common condition associated with poor patient outcomes and increased hospital resource utilization.
Need More Information?
Feel free to ask us anything you need help with.
We’re here to make things easier for you!
